December 25, 2024 07:48 am (IST)
Novo Nordisk launches Ryzodeg in India
Jan 20, 2015, at 04:34 am
New Delhi, Jan 19 (IBNS): Novo Nordisk, the global leader in diabetes care, on Monday announced the launch of Ryzodeg for people with type 2 diabetes in India. Ryzodeg is a combination of two distinct insulin analogues (insulin degludec and insulin aspart in the ratio of 70% and 30%), making it the first combination of a basal insulin with an ultra-long duration of action and a well-established mealtime insulin in one pen 1,2,3.
Latest Headlines
Novo Nordisk launches Ryzodeg in India
Mon, Jan 19 2015